Table: SymBio Pharmaceuticals -2025 parent results

SymBio Pharmaceuticals

05/02/2026 06:32

Feb 5 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           1.31            2.45                                 
               (-46.7 pct)     (-56.1 pct)                             
  Operating     loss 4.58       loss 3.98                              
  Recurring     loss 4.80       loss 3.80                              
  Net           loss 4.90       loss 3.92                              
  EPS        loss 97.62 yen  loss 87.00 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T